Fragile-X is a no brainer for Acadia and I am fairly confident that they WILL start as soon as possible. NEUREN only just got the topline result for one of the phase 2 trials in Dec and Jon did mention on the call that they would be sharing the data with ACADIA when a question was raised about Fragile x.
it takes time to digest the data and have all the preparation work done before initiating the trial
Ann: Comment on research report, page-269
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.58 |
Change
-0.615(3.20%) |
Mkt cap ! $2.383B | |||
| Open | High | Low | Value | Volume |
| $18.98 | $19.15 | $18.50 | $7.940M | 422.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 110 | $18.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.58 | 100 | 6 |
View Market Depth
| Last trade - 15.54pm 02/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |